Not Signed In -
Dermatitis |
Types of dermatitis; Contact Dermatitis; Dermatitis-Atopic Eczema; Dermatitis/Eczema; Rash; Skin Disorders, Dermatitis; Skin Rash; Slide Show: Types of Dermatitis |
Clinical Trial: Standardized Time- and Score-Oriented Treatment of Moderate and Severe Atopic Dermatitis
This study is currently recruiting patients.
Verified by Dresden University of Technology August 2005
|
Purpose
The study was designed to test the hypothesis whether a standardized, time-and score-oriented treatment following a strict evidence based algorithm is equally effective to a standard treatment regimen for moderate to severe atopic dermatitis.
Study Type: Mono-centre study, patients are blinded, physicians are randomized to either treat study- or controll group
Eligible are patients age 2 years or older with SCORAD >= 20 Duration: 12 Months, study visits every 4 weeks.
Primary endpoint is Difference between Baseline SCORAD and mean SCORAD under treatment.
Secundary endpoints are quality of life, safety and economic burden in both treatment groups.
| Condition | Intervention |
|---|---|
| moderate to severe atopic dermatitis | Drug: Pimecrolimus Drug: Tacrolimus Drug: Prednisolone Drug: Ciclosporin A Drug: Dermatop |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Eligibility
Inclusion Criteria:
- Moderate to severe atopic dermatitis (SCORAD 20 or more) fulfilling the diagnostic criteria by Raika and Hanifin
Exclusion Criteria:
- Pregnancy
- Nursing
- Women in childbearing age without contraception
- Drug - and or alcohol abuse
- Gene defects that are associated with increased light sensibility, e.g. Xeroderma pigmentosum, Cockayne Syndrome, Bloom Syndrome
Location and Contact Information
Germany
Department of Dermatology, TU Dresden, Dresden, 01307, Germany; Recruiting
Jochen M Schmitt, MD, MPH, Study Director, Dpt. of Dermatology, Medical Faculty, Technical University Dresden, Germany
More Information
Last Updated: September 7, 2005
Record first received: September 6, 2005
ClinicalTrials.gov Identifier: NCT00148746
Health Authority: Germany: Federal Institute for Drugs and Medicinal Devices
ClinicalTrials.gov processed this record on 2005-09-13
email this page
print this page
bookmark this page
feedback on this page
